ATE135705T1 - Neue 2,6-dialkyl-4-silyl-phenole als antiatherosclerotische mittel und als antioxidantien - Google Patents

Neue 2,6-dialkyl-4-silyl-phenole als antiatherosclerotische mittel und als antioxidantien

Info

Publication number
ATE135705T1
ATE135705T1 AT91111252T AT91111252T ATE135705T1 AT E135705 T1 ATE135705 T1 AT E135705T1 AT 91111252 T AT91111252 T AT 91111252T AT 91111252 T AT91111252 T AT 91111252T AT E135705 T1 ATE135705 T1 AT E135705T1
Authority
AT
Austria
Prior art keywords
silyl
phenols
dialkyl
antioxidants
new
Prior art date
Application number
AT91111252T
Other languages
English (en)
Inventor
Roger A Parker
Simon Jen Tan Mao
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE135705T1 publication Critical patent/ATE135705T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/32Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing two or more of boron, silicon, phosphorus, selenium, tellurium or a metal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AT91111252T 1990-07-05 1991-07-05 Neue 2,6-dialkyl-4-silyl-phenole als antiatherosclerotische mittel und als antioxidantien ATE135705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/548,052 US5155250A (en) 1990-07-05 1990-07-05 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents

Publications (1)

Publication Number Publication Date
ATE135705T1 true ATE135705T1 (de) 1996-04-15

Family

ID=24187205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91111252T ATE135705T1 (de) 1990-07-05 1991-07-05 Neue 2,6-dialkyl-4-silyl-phenole als antiatherosclerotische mittel und als antioxidantien

Country Status (20)

Country Link
US (2) US5155250A (de)
EP (1) EP0464852B1 (de)
JP (1) JP2963556B2 (de)
KR (1) KR0186005B1 (de)
CN (1) CN1029615C (de)
AT (1) ATE135705T1 (de)
AU (1) AU639576B2 (de)
CA (1) CA2046051C (de)
DE (1) DE69118028T2 (de)
DK (1) DK0464852T3 (de)
ES (1) ES2087180T3 (de)
FI (1) FI101703B1 (de)
GR (1) GR3019393T3 (de)
HU (1) HU211074B (de)
IE (1) IE912340A1 (de)
IL (1) IL98712A (de)
NO (1) NO180490C (de)
NZ (1) NZ238808A (de)
PT (1) PT98220B (de)
ZA (1) ZA915074B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238807A (en) * 1990-07-05 1994-03-25 Merrell Dow Pharma Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions
US5304668A (en) * 1990-07-05 1994-04-19 Merrell Dow Pharmaceuticals Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents
FR2707989B1 (fr) * 1993-07-22 1995-10-13 Pf Medicament Nouveaux dérivés de benzylamines silylées, leurs sels, leurs procédés de fabrication et les compositions pharmaceutiques les renfermant.
EP1468693A3 (de) * 1993-12-10 2004-11-03 Merrell Pharmaceuticals Inc. Verwendung von 2,6 - Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Diabetes mellitus
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
EP0734398B1 (de) * 1993-12-15 2002-02-27 Smithkline Beecham Corporation Verbindungen und verfahren
FR2722198B1 (fr) * 1994-07-08 1996-10-04 Pf Medicament 1derives de silylmethyl-anilines, le2fabrication, et leur utilisation co
WO1997040837A1 (en) * 1996-04-30 1997-11-06 Hoechst Marion Roussel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
JP2000511225A (ja) * 1996-05-20 2000-08-29 スミスクライン・ビーチャム・コーポレイション アリール―含有分子の固相有機合成のためのシリルリンカー
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6670398B2 (en) * 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
CA2292388C (en) * 1997-05-14 2004-07-20 Atherogenics, Inc. Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
CN1147495C (zh) * 1997-06-24 2004-04-28 阿温蒂斯药物公司 用作抗氧剂的烷基-4-甲硅烷基杂环酚类和硫酚类
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
WO1998058937A1 (en) * 1997-06-25 1998-12-30 Hoechst Marion Roussel, Inc. 2,6-DI-t-BUTYL-4-[ (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY]PHENOL AND 2,6-DI-t-BUTYL-4-[ (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY]PHENOL
JP2002511878A (ja) * 1997-07-01 2002-04-16 アセロジエニクス・インコーポレイテツド 抗酸化剤による過増殖状態の治療の増強
US6887712B1 (en) 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
EP1137948B1 (de) * 1998-11-09 2006-05-10 Atherogenics, Inc. Methode und zusammensetzungen zum vermindern des cholesterolspiegels im plasma
JP4408982B2 (ja) * 1999-03-31 2010-02-03 東レ・ダウコーニング株式会社 フェノール基含有有機ケイ素化合物およびその製造方法
AU2002248910A1 (en) 2000-11-17 2002-05-27 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrmidines
US20030153536A1 (en) * 2001-10-25 2003-08-14 Mitchell Glass Compounds and methods of treating transplant rejection
US20030181520A1 (en) * 2001-11-09 2003-09-25 Mitchell Glass Methods of reversing and preventing cardiovascular pathologies
MXPA04005864A (es) * 2001-12-19 2004-10-29 Atherogenics Inc Derivados de charcona y su uso para tratar enfermedades.
US6960683B2 (en) * 2002-07-12 2005-11-01 Atherogenics, Inc. Salt forms of poorly soluble probucol esters and ethers
US20040110803A1 (en) * 2002-09-13 2004-06-10 Hossein Dovlatabadi Methods and compositions for the use of D-malic acid to decrease serum triglyceride, cholesterol and lipoprotein levels
AU2003303239A1 (en) * 2002-12-19 2004-07-14 Atherogenics, Inc. Process of making chalcone derivatives
JP4550800B2 (ja) * 2003-01-13 2010-09-22 アセロジエニクス・インコーポレイテツド プロブコールおよびその誘導体のエステルおよびエーテルの製造方法
WO2004108094A2 (en) * 2003-06-06 2004-12-16 Atherogenics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
JP2007509054A (ja) * 2003-10-17 2007-04-12 アミリン・ファーマシューティカルズ,インコーポレイテッド 血管健康を促進するシリルフェノール
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
US20070260087A1 (en) 2004-04-20 2007-11-08 Atherogenics, Inc. Process of Preparing Esters and Ethers of Probucol and Derivatives Thereof
WO2005112914A2 (en) 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
US20060063828A1 (en) * 2004-06-28 2006-03-23 Weingarten M D 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
JP2008505097A (ja) * 2004-07-01 2008-02-21 アセロジエニクス・インコーポレイテツド 糖尿病性血管疾患を治療するための化合物および方法
US8252840B2 (en) * 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
WO2008118946A1 (en) * 2007-03-27 2008-10-02 Atherogenics, Inc. Methods and compositions using certain phenolic derivatives for the treatment of diabetes
DE102007015948A1 (de) * 2007-04-03 2008-10-09 Bayer Materialscience Ag Modifizierte Polycarbonate, Polyestercarbonate und Polyester mit verbessertem Dehnverhalten und Flammwidrigkeit
US20090254425A1 (en) * 2008-04-02 2009-10-08 Evan Horowitz Wiki-type collective intelligence mechanism for implementing a url redirect

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328450A (en) * 1963-01-09 1967-06-27 Dow Corning Silylalkyl phenols
US3506674A (en) * 1967-07-03 1970-04-14 Gen Electric Certain pyridyl thio ether silanes
GB1232394A (de) * 1967-08-17 1971-05-19
US3853776A (en) * 1972-09-29 1974-12-10 Monsanto Co Low pour point fluids and blends containing same
US3801617A (en) * 1973-07-24 1974-04-02 Nasa Thiophenyl ether disiloxanes and trisiloxanes useful as lubricant fluids
DE2933206A1 (de) * 1978-08-18 1980-02-28 Ciba Geigy Ag Phenolhaltige silane und deren verwendung als schmiermittelzusaetze
US4624909A (en) * 1984-04-27 1986-11-25 Nec Corporation Silicon-containing novolak resin and resist material and pattern forming method using same
JPS61263988A (ja) * 1985-05-16 1986-11-21 Shionogi & Co Ltd シリル置換エ−テル類および殺虫・殺ダニ剤
US4636573A (en) * 1985-09-09 1987-01-13 Pastor Stephen D Hindered silicon ester stabilizers
DE3604781A1 (de) * 1986-02-13 1987-08-27 Schering Ag Neue silane, verfahren zu ihrer herstellung und diese verbindungen enthaltende einsektizide mittel
US4804653A (en) * 1986-05-02 1989-02-14 Uniroyal Chemical Company, Inc. Thiomethyl-substituted organosilane compounds and their use as pesticides
DE3638073A1 (de) * 1986-11-07 1988-05-11 Swf Auto Electric Gmbh Vorrichtung, insbesondere hubwischeranlage fuer kraftfahrzeuge
US4783495A (en) * 1987-11-20 1988-11-08 Ciba-Geigy Corporation (Hydroxyphenyl) silane stabilizers
US5138012A (en) * 1988-07-29 1992-08-11 General Electric Company Silicone release coating compositions
DE4031001A1 (de) * 1990-10-01 1992-04-02 Hoechst Ag Verfahren zur herstellung von 4-ethoxyphenyl-3-arylpropyl-(dimethyl)silanen

Also Published As

Publication number Publication date
FI101703B (fi) 1998-08-14
CA2046051A1 (en) 1992-01-06
IE912340A1 (en) 1992-01-15
DK0464852T3 (da) 1996-04-15
HU912272D0 (en) 1991-12-30
NZ238808A (en) 1994-02-25
KR0186005B1 (ko) 1999-05-15
US5532400A (en) 1996-07-02
NO180490C (no) 1997-04-30
NO180490B (no) 1997-01-20
FI913252A0 (fi) 1991-07-04
NO912630L (no) 1992-01-06
IL98712A0 (en) 1992-07-15
FI913252L (fi) 1992-01-06
EP0464852A1 (de) 1992-01-08
ZA915074B (en) 1992-04-29
CN1029615C (zh) 1995-08-30
US5155250A (en) 1992-10-13
PT98220A (pt) 1992-05-29
GR3019393T3 (en) 1996-06-30
AU8011691A (en) 1992-01-09
PT98220B (pt) 1998-12-31
FI101703B1 (fi) 1998-08-14
EP0464852B1 (de) 1996-03-20
IL98712A (en) 1995-11-27
DE69118028T2 (de) 1996-11-28
HU211074B (en) 1995-10-30
CA2046051C (en) 2001-06-05
CN1057843A (zh) 1992-01-15
JPH04230393A (ja) 1992-08-19
NO912630D0 (no) 1991-07-04
ES2087180T3 (es) 1996-07-16
DE69118028D1 (de) 1996-04-25
AU639576B2 (en) 1993-07-29
HUT58749A (en) 1992-03-30
JP2963556B2 (ja) 1999-10-18
KR920002617A (ko) 1992-02-28

Similar Documents

Publication Publication Date Title
ATE135705T1 (de) Neue 2,6-dialkyl-4-silyl-phenole als antiatherosclerotische mittel und als antioxidantien
FI970246A0 (fi) Dihydrobentsofuraanit
ATE156838T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-androstan-3- nen als inhibitoren 5-alpha-reduktases
ATE205472T1 (de) 9-((substituierte glycyl)amido)-6-demethyl-6- deoxytetracycline als antibiotische mittel
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
ATE158300T1 (de) Neue 7-beta-substituierte-4-aza-5-alpha-cholestan-on n als inhibitoren 5-alpha-reduktases
DE69115771D1 (de) Bis (4-(2,6-dialkyl)phenol)silan Derivate als antiatherosclerotische Mittel und als Antioxidantien
DE69717101D1 (de) VERWENDUNG VON alpha-ALKYLGLUCOSIDEN UND DEREN ESTERN ALS ANTIMIKROBIELLE EMULGATOREN
YU33795A (sh) Smese koncentrata suspenzija insekti-cidnih i akaricidnih sredstava arilpirola
DK0743060T3 (da) Anvendelse af tandplejemidler indeholdende bovint colostrum
ATE251457T1 (de) Substituierte 1,2,3,4-tetrahydro-2- dibenzofuranamine und 2- aminocyclohepta(b)benzofurane
DE69209892D1 (de) Neue 2-Mercaptomethylen-tetrahydronaphthalin- und -indan-2-carboxamide als Enkephalinaseinhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee